|
THAP9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.38259999999491E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.425600E-04 |
| Normal-vs-Stage2 |
2.965000E-01 |
| Normal-vs-Stage3 |
2.236100E-02 |
| Normal-vs-Stage4 |
2.552300E-02 |
| Stage1-vs-Stage2 |
4.703200E-01 |
| Stage1-vs-Stage3 |
7.156200E-01 |
| Stage1-vs-Stage4 |
4.852000E-01 |
| Stage2-vs-Stage3 |
3.955200E-01 |
| Stage2-vs-Stage4 |
2.617600E-01 |
| Stage3-vs-Stage4 |
6.769200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.380300E-04 |
| Normal-vs-AfricanAmerican |
2.20289999997014E-06 |
| Normal-vs-Asian |
8.962700E-03 |
| Caucasian-vs-AfricanAmerican |
9.098000E-02 |
| Caucasian-vs-Asian |
4.468800E-01 |
| AfricanAmerican-vs-Asian |
8.886000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.040400E-04 |
| Normal-vs-Female |
2.86140000005375E-06 |
| Male-vs-Female |
1.000560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.431400E-04 |
| Normal-vs-Extreme_Weight |
1.227120E-04 |
| Normal-vs-Obese |
1.658440E-01 |
| Normal-vs-Extreme_Obese |
2.695600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.260400E-01 |
| Normal_Weight-vs-Obese |
1.948590E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.559000E-01 |
| Extreme_Weight-vs-Obese |
2.701800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.210400E-01 |
| Obese-vs-Extreme_Obese |
6.301800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.178100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.492200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.45439999998942E-06 |
| Normal-vs-Age(81-100Yrs) |
8.83340000035204E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.846000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.552000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.865500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.052200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.217300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.662200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.777300E-04 |
| Normal-VS-Type2 PRCC |
3.000800E-03 |
| Normal-VS-KIRP CIMP |
4.37139999975855E-07 |
| Normal-VS-Unclassified PRCC |
3.055900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.456200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.980900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.855600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.277770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.516400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.241500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.196400E-04 |
| Normal-vs-N1 |
5.558900E-03 |
| Normal-vs-N2 |
1.50657999999915E-05 |
| N0-vs-N1 |
9.535000E-01 |
| N0-vs-N2 |
3.557400E-03 |
| N1-vs-N2 |
1.664610E-01 |
|
|
